CPEB4 and glioma: These studies demonstrated that dendritic cells transduced with a CPEB4 expression vector exhibited enhanced antitumor function and induced antitumor immune responses in vitro and in vivo, providing great promise for the treatment of cancer, especially glioma, in the future.